Ovid Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.60

+0.15 (+10.34%)

As of Feb 8, 2:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +2,465.0% upside

Low Target $30.97

Average Target $41.04

High Target $66.83

Current Price $1.60

Current
$1.60

Target
$41.04

$30.97 $41.04 avg $66.83

Scenario Analysis

Bear Case

$30.97

1,835.6%

Low target

Base Case

$41.04

+2,465.0%

Avg target

Bull Case

$66.83

+4,076.9%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$45.41

-96.5% from high

52-Week Low

$28.67

+-94.4% from low

Target vs 52W High

$41.04

-9.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%